Diphtheria Toxoid Antibody, IgG
Corynebacterium diphtheriae is a gram-positive, aerobic bacterium that produces diphtheria toxin, the main virulence factor responsible for disease severity. Diphtheria primarily affects the upper respiratory tract but may also involve skin and other organs. Transmission occurs through respiratory droplets or contact with contaminated surfaces. Once inhaled, the organism colonizes the mucosa of the pharynx, tonsils, or larynx. The diphtheria toxin, encoded by a bacteriophage-carried tox gene, binds to heparin-binding epidermal growth factor receptor (HB-EGF) on host cells, enters the cytosol, and irreversibly inactivates elongation factor-2 (EF-2) by ADP-ribosylation, halting protein synthesis and causing cell death.
The Diphtheria Toxoid Antibody (IgG) test measures IgG antibodies produced in response to diphtheria toxoid vaccination. Protective antibody levels are essential for immunity. Individuals with low or undetectable antibody levels may be susceptible to diphtheria and may require booster immunization.
- Evaluates immune response to diphtheria vaccination
- Identifies individuals who may require booster immunization
Vaccinated: Positive: >=0.01 IU/mL Unvaccinated: Negative: <0.01 IU/mL
Serum, SST tube.
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: 30 days
- Pediatr Res. 1986 Aug;20(8):735-9. [PMID: 3737285]
- Pediatrics. 1984 Jan;73(1):37-42. [PMID: 6318185]
- BMC Infect Dis. 2021 Jun 16;21(1):581. [PMID: 34134646]
- Hum Vaccin Immunother. 2024 Dec 31;20(1):2352909. [PMID: 38752802]